Diisopropylamine → HCID 86693471, compound
Reaction equation
Br[C:2]1[C:3]([F:33])=[CH:4][C:5]2[CH:11]3[CH2:12][CH:9]([CH2:10]3)[N:8]3[C:13]([CH:19]([OH:31])[C:20]4[N:24]([CH:25]5[CH2:30][CH2:29][CH2:28][CH2:27][O:26]5)[N:23]=[CH:22][CH:21]=4)=[C:14]([C:16]([NH2:18])=[O:17])[N:15]=[C:7]3[C:6]=2[CH:32]=1.[C:34]([C:36]1([OH:41])[CH2:40][CH2:39][CH2:38][CH2:37]1)#[CH:35].C(NC(C)C)(C)C>CN(C=O)C>[N:15]1[C:14]([C:16]([NH2:18])=[O:17])=[CH:13][N:8]2[CH:9]3[CH2:12][CH:11]([CH2:10]3)[C:5]3[CH:4]=[CH:3][CH:2]=[CH:32][C:6]=3[C:7]=12.[F:33][C:3]1[C:2]([C:35]#[C:34][C:36]2([OH:41])[CH2:40][CH2:39][CH2:38][CH2:37]2)=[CH:32][C:6]2[C:7]3[N:8]([C:13]([CH:19]([OH:31])[C:20]4[N:24]([CH:25]5[CH2:30][CH2:29][CH2:28][CH2:27][O:26]5)[N:23]=[CH:22][CH:21]=4)=[C:14]([C:16]([NH2:18])=[O:17])[N:15]=3)[CH:9]3[CH2:10][CH:11]([C:5]=2[CH:4]=1)[CH2:12]3Participants
6
Reactant 3
Product 2
Reagents, catalysts & solvents 1
Procedure
9-fluoro-3-(hydroxy(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)methyl)-104(1-hydroxycyclopentyl)ethynyl)-6,7-dihydro-5H-5,7-methanobenzo[c]imidazo[1,2-a]azepine-2-carboxamide was prepared similarly according to General Procedure E with slight modification. 10-bromo-9-fluoro-3-(hydroxy(1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazol-5-yl)methyl)-6,7-dihydro-5H-5,7-methanobenzo[c]imidazo[1,2-a]azepine-2-carboxamide was reacted with 1-ethynylcyclopentanol in a solution of DMF (1.3 mL/mmol) and diisopropylamine (2.6 mL/mmol) to afford the title compound which was carried forward to the next step without further purification.
Sources & evidence
- ORD record
- ord-a32b3df9c97946e2a302f29924e43eef
- Source dataset
- uspto-grants-2015_05
- Patent number
- US09034866B2
Reaction notes
Loading…